Candida infections in the ICU

References

• Daschner FD, Frey P, Wolff G, Baumann PC, Suter P. Nosocomial infections in intensive care wards: a multicenter prospective study. Intensive Care Med 1982; 8: 5–9.
   Google Scholar
• Pittet D, Herwaldt LA, Massanari RM. The Intensive Care Unit. In: Brachman PS, Bennett JV (Eds). Hospital Infections. Boston, Little, Brown and Company, 1992, 405–39.
   Google Scholar
• Beck-Sague CM, Jarvis W. Secular trends in the epidemiology of nosocomial fungal infections in the United States, 1980-1990. National Nosocomial Infections Surveillance System. J Infect Dis 1993; 167: 1247–51.
   Google Scholar
• Jarvis WR, Martone WJ. Predominant pathogens in hospital infections. J Antimicrob Chemother 1992; 29(Suppl A): 19–24.
   Google Scholar
• Komshian SV, Uwaydah AK, Sobel JD, Crane LR. Fungemia caused by Candida species and Torulopsis glabrata in the hospitalized patient: frequency, characteristics, and evaluation of factors influencing outcome. Rev Infect Dis 1989; 11: 379–90.
   PubMedGoogle Scholar
• Solomon SL, Alexander H, Eley JVV etal. Nosocomial fungemia in neonates associated with intravascular pressure-monitoring devices. Pediatr Infect Dis 1986; 5: 680–5.
   Google Scholar
• Solomon SL, Khabbaz RF, Parker RH et al. An outbreak of Candida parapsilosis bloodstream infections in patients receiving parenteral nutrition. J Infect Dis 1984; 149: 98–102.
   PubMed Web of Science ®Google Scholar
• Blinkhorn RJ, Adelstein D, Spagnuolo PJ. Emergence of a new opportunistic pathogen, Candida lusitaniae. J Clin Microbiol 1989; 27: 236–40.
   Google Scholar
• Merz WG, Khazan U, Jabra-Rizk MA, Wu LC, Osterhout GJ, Lehmann PF. Strain delineation and epidemiology of Candida (clavispora) lusitaniae. J Clin Microbiol 1992; 30: 449–54.
   Google Scholar
• Walsh TJ, Salkin IF, Dixon DM, Hurd NJ. Clinical, microbiological, and experimental animal studies of Candida lipolytica. J Clin Microbiol 1989; 27: 927–31.
   PubMed Web of Science ®Google Scholar
• Wingard JR, Merz WG, Rinaldi MG, Johnson TR, Karp JE, Saral R. Increase in Candida krusei infection among patients with bone marrow transplantation and neutropenia treated prophylactically with fluconazole [see comments]. N Engl J Med 1991; 325: 1274–7.
   PubMed Web of Science ®Google Scholar
• Sotiropoulos SV, Jackson MA, Woods GM, Hicks RA, Cullen J, Freeman Al. Alpha-streptococcal septicemia in leukemic children treated with continuous or large dosage intermittent cytosine arabinoside [see comments]. Pediatr Infect Dis J 1989; 8: 755–8.
   PubMed Web of Science ®Google Scholar
• Awada A, Van der Auwera P, Meunier F, Daneau D, Klastersky J. Streptococcal and enterococcal bacteremia in patients with cancer. Clin Infect Dis 1992; 15: 33–48.
   PubMed Web of Science ®Google Scholar
• Jacoby GA, Archer GL. New mechanisms of bacterial resistanceto antimicrobial agents. N Engl J Med 1991; 324: 601–12.
   PubMed Web of Science ®Google Scholar
• Elting LS, Bodey GP. Septicemia due to Xanthomonas species and non-aeruginosa Pseudomonas species: increasing incidence of catheter-related infections. Medicine (Baltimore) 1990; 69: 296–306.
   PubMed Web of Science ®Google Scholar
• Pfaller M, Wenzel R. Impact of the changing epidemiology of fungal infections in the 1990s. Eur J Clin Microbiol Infect Dis 1992; 11: 287–91.
   PubMed Web of Science ®Google Scholar
• Pittet D, Wenzel RP. Nosocomial bloodstream infections: secular trends in rates, mortality, and contribution to total hospital deaths. Arch Intern Med 1995; 155: 1177–84.
   PubMed Web of Science ®Google Scholar
• Horn R, Wong B, Kiehn TE, Armstrong D. Fungemia in a cancer hospital: changing frequency, earlier onset, and results of therapy. Rev Infect Dis 1985; 7: 646–55.
   PubMedGoogle Scholar
• Solomkin JS, Flohr AB, Quie PG, Simmons RL. The role of Candida in intraperitoneal infections. Surgery 1980; 88: 524–30.
   PubMed Web of Science ®Google Scholar
• Sobel JD. Candida infections in the intensive care unit. Crit Care Med 1988; 4: 325–44.
   Google Scholar
• Meunier F, Aoun M, Bitar N. Candidemia in immunocompro-mised patients. Clin Infect Dis 1992; 14(Suppl 1): 120–5.
   Google Scholar
• Grayb ill JR, Sharkey PK. Fungal infections and their management. Br J Clin Pract Symp Suppl 1990; 71: 23–31.
   PubMedGoogle Scholar
• Nassoura Z, Ivatury RR, Simon RJ, Jabbour N, Stahl WI\4. Candiduria as an early marker of disseminated infection in critically ill surgical patients: the role of fluconazole therapy. J Trauma 1993; 35: 290–4.
   Google Scholar
• Persons DA, Laughlin M, Tanner D, Perfect J, Gockerman JP, Hathorn JW. Fluconazole and Candida krusei fungemia. N Engl J Med 1991; 325: 1315 (Letter).
   Google Scholar
• Branchini ML, Pfaller MA, Rhine Chalberg J, Frempong T, Isenberg HD. Genotypic variation and slime production among blood and catheter isolates of Candida parapsilosis. J Clin Microbiol 1994; 32: 452–6.
   Google Scholar
• Wey SB, Motomi M, Pfaller MA, Woolson RF, Wenzel RP. Hospital-acquired candidemia. The attributable mortality and excess length of stay. Arch Intern Med 1988; 148: 2642–2645.
   Google Scholar
• Miller PJ, Wenzel RP. Etiologic organisms as independent predictors of death and morbidity associated with bloodstream infections. J Infect Dis 1987; 156: 471–7.
   PubMed Web of Science ®Google Scholar
• Bross J, Talbot GH, Maislin G, Hurwits S, Strom BL. Risk factors for nosocomial candidemia: a case-control study in adults without leukemia. Am J Med 1989; 87: 614–20.
   Google Scholar
• Pittet D, Li N, Woolson RF, Wenzel RP. Microbiological factors influencing the outcome of nosocomial bloodstream infections. A six year validated, population-based model. Clin Infect Dis 1997; 24: 1068–78.
   Google Scholar
• Wey SB, Mori M, Pfaller MA, Woolson RF, Wenzel RP. Risk factors for hospital-acquired candidemia. A matched case-control study. Arch Intern Med 1989; 149: 2349–53.
   PubMedGoogle Scholar
• Pittet D. Nosocomial bloodstream infections. In: Wenzel RP (Ed). Prevention and control of nosocomial infections. Baltimore, Williams and Wilkins, 1993, 512–55.
   Google Scholar
• Harbarth S, Pittet D. Excess mortality and impact of intensive care unit-acquired infections. Curr Opin Anaesth 1996; 9: 139–45.
   Google Scholar
• Pittet D, Tarara D, Wenzel RP. Nosocomial bloodstream infection in critically ill patients: excess length of stay, extra costs, and attributable mortality. JAMA 1994; 271: 1598–601.
   Google Scholar
• Eubanks PJ, de Virgilio C, Klein S, Bongard F. Candida sepsis in surgical patients. Am J Surg 1993; 166: 617–19.
   PubMed Web of Science ®Google Scholar
• Tang E, Tang G, Berne TV. Prognostic indicators in fungemia of the surgical patient. Arch Surg 1993; 128: 759–62.
   Google Scholar
• Ekenna O, Sherertz RJ, Bingham H. Natural history of blood-stream infections in a burn patient population: the importance of candidemia. Am J Infect Control 1993; 21: 189–95.
   Google Scholar
• Pittet D, Monod M, Filthuth I, Frenk E, Suter PM, Auckenthaler R. Contour-clamped homogeneous electric field gel electrophoresis as a powerful epidemiologic tool in yeast infections. Am J Med 1991; 91: 256–63S.
   Google Scholar
• Pittet D, Li N, Wenzel RP. Association of secondary and polymicrobial nosocomial bloodstream infections with higher mortality. Eur J Clin Microbiol Infect Dis 1993; 12: 813–19 (Abstr).
   PubMed Web of Science ®Google Scholar
• Voss A, Hollis RJ, Pfaller MA, Wenzel RP, Doebbeling BN. Investigation of the sequence of colonization and candidemia in nonneutropenic patients. J Clin Microbiol 1994; 32: 975–80.
   Google Scholar
• Craven DE, Kunches LM, Lichtenberg DA. Nosocomial infection and fatality in medical surgical intensive care unit patients. Arch Intern Med 1988; 148: 1161–8.
   Google Scholar
• Gross PA, DeMauro PJ, Van Antwerpen C, Wallenstein S, Chiang S. Number of comorbidities as a predictor of nosocomial infection acquisition. Infect Control Hosp Epidemiol 1988; 9: 497–500.
   PubMedGoogle Scholar
• Richet HM, Andremont A, Tancrede C, Pico JL, Jarvis WR. Risk factors for candidemia in patients with acute lymphocytic leukemia. Rev Infect Dis 1991; 13: 211–15.
   Google Scholar
• Pittet D, Monod M, Suter PM, Frenk E, Auckenthaler R. Candida colonization and subsequent infections in critically ill surgical patients. Ann Surg 1994; 220: 751–8.
   Google Scholar
• Ang BS, Telenti A, King B, Steckelberg JM, Wilson WR. Candidemia from a urinary tract source: microbiological aspects and clinical significance. Clin Infect Dis 1993; 17: 662–6.
   Google Scholar
• Singh N, Mieles L, Yu VL, Gayowski T. Invasive aspergillosis in liver transplant recipients: association with candidemia and consumption coagulopathy and failure of prophylaxis with low-dose amphotericin B. Clin Infect Dis 1993; 17: 906–8.
   PubMed Web of Science ®Google Scholar
• Solomkin JS, Flohr AB, Simmons RL. Indications for therapy for fungemia in postoperative patients. Arch Surg 1982; 117: 1272–5.
   Google Scholar
• Rantala A, Niinikoski J, Lehtonen OP. Early Candida isolations in febrile patients after abdominal surgery. Scand J Infect Dis 1993; 25: 479–85.
   Google Scholar
• Pappu-Katikaneni LD, Rao KP, Banister E. Gastrointestinal colonization with yeast species and Candida septicemia in very low birth weight infants. Mycoses 1990; 33: 20–3.
   Google Scholar
• Slotman GJ, Shapiro E, Moffa SM. Fungal sepsis: multisite colonization versus fungemia. Am Surg 1994; 60: 107–13.
   Google Scholar
• Reagan DR, Pfaller MA, Hollis RJ, Wenzel RP. Characterization of the sequence of colonization and nosocomial candidemia using DNA fingerprinting and a DNA probe. J Clin Microbiol 1990; 28: 2733–8.
   PubMed Web of Science ®Google Scholar
• Burnie JP, Odds FC, Lee W, Webster C, Williams J. Outbreak of systemic Candida albicans in intensive care unit caused by cross infection. BMJ 1985; 290: 746–8.
   Google Scholar
• Stevens DA, Odds FC, Scherer S. Applications of DNA typing methods to Candida albicans epidemiology and correlations with phenotype. Rev Infect Dis 1990; 12: 258–66.
   Google Scholar
• Romano F, Ribera G, Giuliano M. A study of a hospital cluster of systemic candidosis using DNA typing methods. Epidemiol Infect 1994; 112: 393–8.
   Google Scholar
• Vaudry WL, Tierney AJ, Wenman WI\4. Investigation of a cluster of systemic Candida albicans infections in a neonatal intensive care unit. J Infect Dis 1988; 158: 1375–9.
   Google Scholar
• Doebbeling BN, Pfaller MA, Houston AK, Wenzel RP. Removal ofnosocomial pathogens from the contaminated glove. implications for glove reuse and handwashing. Ann Intern Med 1988; 109: 394–8.
   PubMed Web of Science ®Google Scholar
• Doebbeling BN, Stanley GL, Sheetz CT et al. Comparative efficacy of alternative hand-washing agents in reducing nosocomial infections in intensive care units. N Engl J Med 1992; 327: 88–93.
   PubMed Web of Science ®Google Scholar
• Rangel-Frausto SS, Martin MA, Saiman L et al. High-prevalence of Candida spp. on hands of health care workers in surgical and neonatal intensive care units: a multicenter study. Orlando, 34th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, 1994, J106 (Abstr).
   Google Scholar
• Lee W, Burnie JP, Matthews RC, Oppenheim BO, Damani NN. Hospital outbreaks with yeasts. J Hosp Infect 1991; 18(Suppl A): 237–49.
   Google Scholar
• Guerra-Romero L, Edson RS, Cockerill FR, Horstmeier CD, Roberts GD. Comparison of Du Pont Isolator and Roche Septi-Chek for detection of fungemia. J Clin Microbiol 1987; 25: 1623–5.
   Google Scholar
• Isenberg DD, Tucci V, Cintron F, Singer C, Weinstein GS, Tyras DH. Single-source outbreak of Candida tropicalis complicating coronary bypass surgery. J Clin Microbiol 1989; 27: 2426–8.
   PubMed Web of Science ®Google Scholar
• Harbarth S, Pittet D. Identification and management of infectious outbreaks in the critical care unit. Curr Opin Crit Care 1996; 2: 352–60.
   Google Scholar
• Wong-Beringer A, Jacobs RA, Guglielmo BJ. Nosocomial funguria: resultant morbidity and therapeutic intervention. Clin Infect Dis 1993; 17: 1066–7.
   Google Scholar
• Haron E, Vartivarian S, Anaissie E, Dekmezian R, Bodey GP. Primary Candida pneumonia. Experience at a large center cancer and review of the literature. Medicine (Baltimore) 1993; 72: 137–42.
   Google Scholar
• Hiatt JR, Kobayashi MR, Doty JE, Ramming KP. Acalculous candida cholecystitis: a complication of critical surgical illness. Am J Surg 1991; 57: 825–9.
   Google Scholar
• Jones JM. Laboratory diagnosis of invasive candidiasis. Clin Microbiol Rev 1990; 3: 32–45.
   PubMed Web of Science ®Google Scholar
• Morhart M, Rennie R, Ziola B, Bow E, Louie TJ. Evaluation of enzyme immunoassay for Candida cytoplasmic antigens in neutropenic cancer patients. J Clin Microbiol 1994; 32: 766–76.
   Google Scholar
• Donahue SP, Greven CM, Zuravleff JJ et al. Intraocular candidiasis in patients with candidemia. Clinical implications derived from a prospective multicenter study. Ophthalmology 1994; 101: 1302–9.
   Google Scholar
• Rex JH, Bennett JE, Sugar AM et al. A randomized trial comparing fluconazole with amphotericin B for the treatment of candidemia in patients without neutropenia. N Engl J Med 1994; 331: 1325–30.
   PubMed Web of Science ®Google Scholar
• Pittet D, Anaissie E, Solomkin JS. When to start antifungal therapy in the nonneutropenic critically ill ? In: Vincent IL (Ed). Yearbook of Intensive Care and Emergency Medicine. Berlin, Springer-Verlag, 1996, 567–77.
   Google Scholar
• Dick JD, Rosengard BR, Merz WG, Stuart RK, Hutchins GM, Saral R. Fatal disseminated candidiasis due to amphotericin-B-resistant candida guilliermondii. Ann Intern Med 1985; 102: 67–8.
   PubMed Web of Science ®Google Scholar
• Merz WG. Candida lusitaniae: frequency of recovery, colonization, infection, and amphotericin B resistance. J Clin Microbiol 1984; 20: 1194–5.
   PubMed Web of Science ®Google Scholar
• Meunier F. Management of candidemia [editorial; comment]. N Engl J Med 1994; 331: 1371–2.
   PubMed Web of Science ®Google Scholar
• Grasela TH, Pasko MT, Goodwin SD, Walawander CA, Blackwelder N, Bruder Holt RJ. Use of antifungal therapy in hospitalized patients. II. Results after the marketing of fluconazole. Ann Pharmacother 1994; 28: 261–70.
   Google Scholar
• Como JA, Dismukes WE. Oral azole drugs as systemic antifungal therapy [see comments]. N Engl J Med 1994; 330: 263–72.
   PubMed Web of Science ®Google Scholar
• Armstrong D. Treatment of opportunistic fungal infections. Clin Infect Dis 1993; 16: 1–9.
   PubMed Web of Science ®Google Scholar
• Bennett JE, Dismukes WE, Duma RJ et al. A comparison of amphotericin B alone and combined with flucytosine in the treatment of cryptoccal meningitis. N Engl J Med 1979; 301: 126–31.
   PubMed Web of Science ®Google Scholar
• Lopez-Berestein G, Fainstein V, Hopfer RL et al. Liposomal amphotericin B (AmBisome) in the treatment of fungal infections in patients with cancer: a preliminary study. J Infect Dis 1984; 151: 704–10.
   Web of Science ®Google Scholar
• Caillot D, Chavanet P, Casasnovas O et al. Clinical evaluation of a new lipid-based delivery system for intravenous administration of amphotericin B. Eur J Clin Microbiol Infect Dis 1992; 11: 722–5.
   PubMed Web of Science ®Google Scholar
• Chavanet P, Charlier N, Brenet A et al. Emulsion of amphotericin B in Intralipid 20%: in vitro efficacy. Pathol Biol (Paris) 1992; 40: 507–12.
   PubMed Web of Science ®Google Scholar
• Pittet D, Garbino J. Fungal infections in the critically ill. Curr Opin Grit Care 1995; 1: 369–80.
   Google Scholar
• NoIla Salas J, Leon C, Torres Rodriguez JM, Martin E, Sitges Serra A. Treatment of candidemia in critically ill surgical patients with intravenous fluconazole. Gun Infect Dis 1992; 14: 952–4.
   Google Scholar
• Graninger W, Presteril E, Schneeweiss B, Teleky B, Georgopoulos A. Treatment of Candida albicans fungaemia with fluconazole. J Infect 1993; 26: 133–46.
   Google Scholar
• Price MF, LaRocco MT, Gentry LO. Fluconazole susceptibilities of Candida species and distribution of species recovered from blood cultures over a 5-year period. Antimicrob Agents Chemother 1994; 38: 1422–7.
   Google Scholar
• Hanson LH, Stevens DA. Evaluation of cilofungin, a lipopeptideantifungal agent, in vitro against fungi isolated from clinical specimens. Antimicrob Agents Chemother 1989; 33: 1391–2.
   PubMed Web of Science ®Google Scholar
• Lefler E, Stevens DA, 33. Inhibition and killing of Candida albicans in vitro by five imidazoles in clinical use. Antimicrob Agents Chemother 1984; 25: 450–4.
   Google Scholar
• Tucker RM, Hanson LH, Brummer E, Stevens DA, 35: Activity of ICI 195,739, a new oral triazole, compared with that of ketoconazole in the therapy of experimental murine blasto-mycosis. Antimicrob Agents Chemother 1989; 33: 573–5.
   PubMed Web of Science ®Google Scholar
• Morozumi PA, Brummer E, Stevens DA. Immunostimulation with muramyl dipeptide and its desmethyl analogue: studies of non-specific resistance to pulmonary blastomycosis in inbred mouse strains. Mycopathologia 1983; 81: 35–9.
   Google Scholar
• Stevens DA. Management of systemic manifestations of fungal disease in patients with AIDS. J Am Acad Dermatol 1994; 31: S64–7.
   PubMed Web of Science ®Google Scholar
• Hostetler JS, Brummer E, Coffman RL, Stevens DA. Effect of anti-il-4, interferon-gamma and an antifungal triazole (sch 42427) in paracoccidioidomycosis: correlation of ige levels with outcome. Clin Exp Immunol 1993; 94: 11–16.
   PubMed Web of Science ®Google Scholar
• Hostetler JS, Hanson LH, Stevens DA. Effect of cyclodextrin on the pharmacology of antifungal oral azoles. Antimicrob Agents Chemother 1992; 36: 477–80.
   PubMed Web of Science ®Google Scholar
• Hostetler JS, Hanson LH, Stevens DA. Effect of hydroxypropyl-beta-cyclodextrin on efficacy of oral itraconazole in disseminated murine cryptococcosis. J Antimicrob Chemother 1993; 32: 459–63.
   Google Scholar
• Dube MP, Heseltine PN, Rinaldi MG, Evans S, Zawacki B. Fungemia and colonization with nystatin-resistant Candida rugosa in a burn unit. Clin Infect Dis 1994; 18: 77–82.
   Google Scholar
• Green D, Still JMJ, Law EJ. Candida parapsilosis sepsis in patients with burns: report of six cases. J Burn Care Rehabil 1994; 15: 240–3.
   Google Scholar
• Casasnovas RO, Caillot D, Solary E et al. Prophylactic fluconazole and Candida krusei infection. N EnglJ Med 1992; 326: 891–3 (Letter).
   PubMed Web of Science ®Google Scholar
• Scholten SL, Nettleman MD, Sarrazin EF. Prophylactic fluconazole and marrow transplantation. N Engl J Med 1992; 327: 644–5 (Letter).
   Google Scholar
• Boken DJ, Swindells S, Rinaldi MG. Fluconazole-resistant Candida albicans. Clin Infect Dis 1993; 17: 1018–21.
   PubMed Web of Science ®Google Scholar
• British Society for Antimicrobial Chemotherapy. Management of deep Candida infection in surgical and intensive care unit patients. Intensive Care Med 1994; 20: 522–8.
   PubMed Web of Science ®Google Scholar
• McQuillen DP, Zingman BS, Meunier F, Levitz SM. Invasive infections due to Candida krusei: report often cases of fungemia that include three cases of endophthalmitis. Clin Infect Dis 1992; 14: 472–8.
   PubMed Web of Science ®Google Scholar